Penserra Capital Management LLC - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 117 filers reported holding TCR2 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$7,000
-50.0%
875
+0.6%
0.00%
Q2 2021$14,000
-22.2%
870
+1.8%
0.00%
Q1 2021$18,000
-21.7%
855
+11.8%
0.00%
-100.0%
Q4 2020$23,0007650.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$62,221,00018.51%
MPM BioImpact LLC 3,370,982$51,778,00013.77%
Redmile Group, LLC 1,765,188$27,113,0000.50%
ArrowMark Colorado Holdings LLC 1,356,010$20,828,0000.22%
DAFNA Capital Management LLC 46,183$709,0000.20%
Artal Group S.A. 350,000$5,376,0000.15%
WFA of San Diego, LLC 4,733$540,0000.13%
Granite Point Capital Management, L.P. 100,000$1,536,0000.08%
HHLR ADVISORS, LTD. 322,903$4,960,0000.04%
SPHERA FUNDS MANAGEMENT LTD. 30,000$461,0000.04%
View complete list of TCR2 THERAPEUTICS INC shareholders